Hemogenyx Pharmaceuticals Plc (HOPHF)
OTCMKTS · Delayed Price · Currency is USD
1.240
+1.200 (3,000.00%)
Mar 7, 2025, 4:00 PM EDT

Hemogenyx Pharmaceuticals Market Cap

Hemogenyx Pharmaceuticals has a market cap or net worth of $10.29 million as of May 23, 2025. Its market cap has decreased by -60.19% in one year.

Market Cap
10.29M
Enterprise Value
13.54M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.24

Market Cap Chart

Since October 6, 2017, Hemogenyx Pharmaceuticals's market cap has decreased from 13.93M to 10.29M, a decrease of -26.11%. That is a compound annual growth rate of -3.89%.

History

DateMarket Cap% Change
May 22, 202510.29M-42.07%
Dec 31, 202417.77M-48.41%
Dec 29, 202334.44M120.18%
Dec 30, 202215.64M-37.12%
Dec 31, 202124.87M-56.46%
Dec 31, 202057.13M512.38%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Endo Inc. 1.63B
Veradigm 747.23M
Nika Pharmaceuticals 672.83M
Tian'an Technology Group 591.73M
Elite Pharmaceuticals 551.66M
Glass House Brands 483.63M
CytoDyn 481.37M
Northwest Biotherapeutics 420.38M
Market Cap Rankings